Form 4: Intelligent Bio Solutions CFO Receives Stock Grant and Corrects Previous Reporting Errors

Spiro Kevin Sakiris, CFO of Intelligent Bio Solutions Inc., received 34,500 shares of common stock and corrected clerical errors in previous filings regarding his holdings.

Summary

• On September 25, 2024, Intelligent Bio Solutions Inc. granted Spiro Kevin Sakiris, the company's CFO, 34,500 shares of common stock under the 2019 Long Term Incentive Plan.
• Sakiris's reported securities holdings were adjusted to correct clerical errors.
• One correction increased his direct holdings by 1 share, and another decreased his indirect holdings by 236 shares.
• After these transactions, Sakiris directly owns 34,815 shares of common stock.
• He also indirectly owns 18,944 shares through Anest Holdings Pty Ltd, as trustee of ATF S&T Sakiris Superannuation Fund, where he serves as a director.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing. The stock grant is a positive sign, but the corrections of errors are neutral.

Positives

• The grant of 34,500 shares to the CFO may be seen as a positive incentive and alignment of interests with shareholders.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, ensuring fair markets.

Stakeholder Impact

• Shareholders may view the stock grant as a positive incentive for the CFO.
• The corrections of previous reporting errors ensure transparency and accuracy in financial disclosures.

Key Dates

Keywords

Form 4, beneficial ownership, Spiro Sakiris, Intelligent Bio Solutions Inc., INBS, CFO, stock grant, securities, holdings, correction